...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.
【24h】

Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.

机译:卡马西平体外生物活化的途径I.负责形成2和3羟基化代谢物的人类细胞色素P450的表征。

获取原文
获取原文并翻译 | 示例

摘要

In vitro studies were conducted to identify the cytochromes P450 (P450s) involved in the formation of 2- and 3-hydroxycarbamazepine, metabolites that may serve as precursors in the formation of protein-reactive metabolites. Human liver microsomes (HLMs) converted carbamazepine (30-300 microM) to 3-hydroxycarbamazepine at rates >25 times those of 2-hydroxycarbamazepine. Both the 2- and 3-hydroxylation of carbamazepine appeared to conform to monophasic Michaelis-Menten kinetics in HLMs (apparent K(m) values, approximately 1640 and approximately 217 microM; apparent V(max) values, approximately 5.71 and approximately 46.9 pmol/mg of protein/min, respectively). Rates of carbamazepine 2- and 3-hydroxylation correlated strongly with CYP2B6 activity (r >or= 0.757) in a panel of HLMs (n = 8). Carbamazepine 3-hydroxylation also correlated significantly with CYP2C8 activity at a carbamazepine concentration of 30 microM. Formation of 2- and 3-hydroxycarbamazepine did not correlate significantly with any other P450 activities. The chemical inhibitors ketoconazole (CYP3A) and 7-EFC (CYP2B6) inhibited both 2- and 3-hydroxycarbamazepine formation whereas 4-methylpyrazole (CYP2E1) markedly decreased 2-hydroxycarbamazepine formation. Several recombinant P450s catalyzed carbamazepine 2- and 3-hydroxylation, but after adjustment for relative hepatic abundance, CYP3A4 and CYP2B6 appeared to be the major catalysts of carbamazepine 3-hydroxylase activity, and at least five P450s were significant contributors to 2-hydroxycarbamazepine formation; CYP2E1 made the greatest contribution to the Cl(int) of carbamazepine 2-hydroxylation (approximately 30%), but P450s CYP1A2, 2A6, 2B6, and 3A4 also made significant contributions (approximately 13-18%). These results suggest that CYP2B6 and CYP3A4 are largely responsible for the formation of 3-hyrdoxycarbamazepine, whereas multiple P450s (CYP1A2, 2A6, 2B6, 2E1, and 3A4) contributed to 2-hydroxycarbamazepine formation.
机译:进行了体外研究,以鉴定参与形成2和3羟基卡马西平的代谢物的细胞色素P450(P450),这些代谢物可以作为蛋白质反应性代谢物形成的前体。人肝微粒体(HLM)将卡马西平(30-300 microM)转化为3-羟基卡马西平的速率> 2-羟基卡马西平的25倍。卡马西平的2-和3-羟基化似乎都符合HLM中的单相Michaelis-Menten动力学(表观K(m)值约为1640和217 microM;表观V(max)值约为5.71和46.9 pmol /毫克蛋白质/分钟)。在一组HLM中,卡马西平2-和3-羟基化的速率与CYP2B6活性强烈相关(r>或= 0.757)(n = 8)。卡马西平浓度为30 microM时,卡马西平3-羟基化作用也与CYP2C8活性显着相关。 2-和3-羟基卡马西平的形成与任何其他P450活性均无显着相关性。化学抑制剂酮康唑(CYP3A)和7-EFC(CYP2B6)抑制2-和3-羟基卡马西平的形成,而4-甲基吡唑(CYP2E1)显着降低2-羟基卡马西平的形成。几种重组P450催化了卡马西平的2-和3-羟基化反应,但是在调整了相对肝脏丰度后,CYP3A4和CYP2B6似乎是卡马西平3-羟化酶活性的主要催化剂,并且至少有五个P450是2-羟基卡马西平形成的重要贡献者。 CYP2E1对卡马西平2-羟基化的Cl(int)的贡献最大(约30%),但P450s CYP1A2、2A6、2B6和3A4的贡献也很大(约13-18%)。这些结果表明CYP2B6和CYP3A4在很大程度上负责3-羟基卡马西平的形成,而多个P450(CYP1A2、2A6、2B6、2E1和3A4)促成2-羟基卡马西平的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号